ATE197155T1 - Stannius- körperchen -protein, stanniocalcin - Google Patents

Stannius- körperchen -protein, stanniocalcin

Info

Publication number
ATE197155T1
ATE197155T1 AT94923154T AT94923154T ATE197155T1 AT E197155 T1 ATE197155 T1 AT E197155T1 AT 94923154 T AT94923154 T AT 94923154T AT 94923154 T AT94923154 T AT 94923154T AT E197155 T1 ATE197155 T1 AT E197155T1
Authority
AT
Austria
Prior art keywords
polypeptides
stannius
polypeptide
stanniocalcin
body protein
Prior art date
Application number
AT94923154T
Other languages
English (en)
Inventor
Henrik Olsen
Mark D Adams
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Application granted granted Critical
Publication of ATE197155T1 publication Critical patent/ATE197155T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system
    • Y10S530/835—Kidney

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
AT94923154T 1994-03-08 1994-05-09 Stannius- körperchen -protein, stanniocalcin ATE197155T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/208,005 US5837498A (en) 1994-03-08 1994-03-08 Corpuscles of stannius protein, stanniocalcin
PCT/US1994/005136 WO1995024411A1 (en) 1994-03-08 1994-05-09 Corpuscles of stannius protein, stanniocalcin

Publications (1)

Publication Number Publication Date
ATE197155T1 true ATE197155T1 (de) 2000-11-15

Family

ID=22772838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94923154T ATE197155T1 (de) 1994-03-08 1994-05-09 Stannius- körperchen -protein, stanniocalcin

Country Status (15)

Country Link
US (5) US5837498A (de)
EP (1) EP0750626B1 (de)
JP (1) JP3687974B2 (de)
KR (1) KR100338583B1 (de)
CN (2) CN1560080A (de)
AT (1) ATE197155T1 (de)
AU (1) AU684297B2 (de)
CA (1) CA2184905A1 (de)
DE (1) DE69426209T2 (de)
DK (1) DK0750626T3 (de)
ES (1) ES2151557T3 (de)
GR (1) GR3035099T3 (de)
PT (1) PT750626E (de)
WO (1) WO1995024411A1 (de)
ZA (1) ZA943702B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837498A (en) * 1994-03-08 1998-11-17 Human Genome Scienes, Inc. Corpuscles of stannius protein, stanniocalcin
WO1996015147A1 (en) * 1994-11-10 1996-05-23 Human Genome Sciences, Inc. Human stanniocalcin-alpha
US6008322A (en) * 1996-04-02 1999-12-28 Zymogenetics, Inc. Stanniocalcin-2
WO1999033864A1 (fr) * 1997-12-26 1999-07-08 Daiichi Pharmaceutical Co., Ltd. Derives peptidiques
EP1121936B1 (de) * 1998-09-17 2005-11-30 Daiichi Pharmaceutical Co., Ltd. Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit
CA2387685A1 (en) * 1999-10-27 2001-05-03 Human Genome Sciences, Inc. Stanniocalcin proteins and nucleic acids and methods based thereon
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
EP1227841A4 (de) 1999-11-04 2003-01-22 Diadexus Inc Ein neuartiges verfahren zur diagnose, darstellung, bewertung, bildgebung und behandlung von krebs
CA2415709A1 (en) * 2000-07-11 2003-01-10 Bml, Inc. Remedies for bone diseases
US20040009171A1 (en) * 2001-10-18 2004-01-15 Genentech, Inc. Methods for the treatment of carcinoma
EP1442062A4 (de) * 2001-10-18 2005-11-09 Genentech Inc Verfahren zur behandlung von karzinomen
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
US8759298B2 (en) 2010-05-03 2014-06-24 Scott & White Healthcare Protein therapy for corneal inflammation, epithelial wound healing, and photoreceptor degeneration
TW202235618A (zh) * 2021-01-05 2022-09-16 美國馬友醫藥教育研究基金會 治療眼內壓相關疾患

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447841A (en) * 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
WO1988003949A1 (en) * 1986-11-21 1988-06-02 Howard Florey Institute Of Experimental Physiology The cs protein of the corpuscles of stannius
US5491224A (en) * 1990-09-20 1996-02-13 Bittner; Michael L. Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture
US5538869A (en) * 1990-12-13 1996-07-23 Board Of Regents, The University Of Texas System In-situ hybridization probes for identification and banding of specific human chromosomes and regions
US5866344A (en) * 1991-11-15 1999-02-02 Board Of Regents, The University Of Texas System Antibody selection methods using cell surface expressed libraries
US5545524A (en) * 1991-12-04 1996-08-13 The Regents Of The University Of Michigan Compositions and methods for chromosome region-specific probes
US5837498A (en) * 1994-03-08 1998-11-17 Human Genome Scienes, Inc. Corpuscles of stannius protein, stanniocalcin

Also Published As

Publication number Publication date
US20020146791A1 (en) 2002-10-10
EP0750626A1 (de) 1997-01-02
DK0750626T3 (da) 2000-11-20
EP0750626A4 (de) 1997-06-11
CA2184905A1 (en) 1995-09-14
US5877290A (en) 1999-03-02
GR3035099T3 (en) 2001-03-30
KR100338583B1 (ko) 2002-11-14
US5837498A (en) 1998-11-17
JP3687974B2 (ja) 2005-08-24
AU7310994A (en) 1995-09-25
CN1178950C (zh) 2004-12-08
CN1143371A (zh) 1997-02-19
ZA943702B (en) 1995-11-27
JPH09511140A (ja) 1997-11-11
US7326537B2 (en) 2008-02-05
KR970701724A (ko) 1997-04-12
US5994301A (en) 1999-11-30
DE69426209D1 (de) 2000-11-30
PT750626E (pt) 2001-03-30
CN1560080A (zh) 2005-01-05
DE69426209T2 (de) 2001-06-07
EP0750626B1 (de) 2000-10-25
US20050208552A1 (en) 2005-09-22
ES2151557T3 (es) 2001-01-01
WO1995024411A1 (en) 1995-09-14
AU684297B2 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
DK165506C (da) Proteinpraeparat med koagulationsaktivitet samt fremgangsmaade til fremstilling deraf
DE69426209D1 (de) Stannius- körperchen -protein, stanniocalcin
ATE117437T1 (de) Test von einer körperflüssigkeit zur messung von knochenresorption.
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
GR860576B (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
Odani et al. Purification and complete amino acid sequence of novel β2-microglobulin
ATE328281T1 (de) Methode zur diagnose von abnormalem knochenstoffwechsel
EP0789076A3 (de) Protein-G-gekoppelter Rezeptorproteine, deren Herstellung und Verwendung
JPS646219A (en) Peptide having promoting action on activation of protein c by thrombin
DE69736158D1 (de) Glutamine: Fructose-6-Phosphat Amidotransferase (GFAT), ihre Herstellung und Verwendung
EP0834568A3 (de) Speichel-bindendes Protein von Streptococcus pneumoniae
Brandt et al. A novel molecular variant of the neutrophil-activating peptide NAP-2 with enhanced biological activity is truncated at the C-terminus: identification by antibodies with defined epitope specificity
EP0846763A3 (de) R5, ein Protein Phosphatase-1 bindendes Protein
NO962596L (no) Nytt tumorsupressorgen
Ledden et al. Characterization of fragments of human albumin purified by Cibacron Blue F3GA affinity chromatography
DE MARCUCCI et al. Immune-mapping as a specific and sensitive probe for the characterization of proteins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee